上客户端，和病友交流

点击下载

淋巴瘤

Jeffrey Zonder M.D.

内科

Karmanos cancer center

擅长疾病

临床新药咨询

通过咨询找到适合自己的药物

去咨询

专家会诊咨询

专业、及时的一对一咨询

去咨询

如果您的问题未能解决，您还可以选择：

医学顾问

: 极速问诊

2万名名医
7*24小时为您匹配

1对1

: 找专家

肿瘤专科专家
对症找医专科专治

专家介绍

2015-06-17 16:051997

· Gender

· Male

· Multidisciplinary Team(s)

· Hematologic (Malignant)

· Department/Research Program(s)

· Department of Oncology

· Cancer Type(s)

· Multiple Myeloma
Amyloidosis
Non-Hodgkin's Lymphoma
Leukemia
Plasmacytoma

· Contact Info

· Email:
zonderj@karmanos.org

来自 <http://www.karmanos.org/physicians/Jeffrey-Zonder?Disease=73&PageIndex=0&SortDirection=1>

· Education

· Fellowship
Hematology/oncology Fellow, Wayne State University, Detroit Medical Center, Detroit, MI
Fellowship
Hematology/oncology Chief Fellow, Wayne State University, Detroit Medical Center, Detroit, MI
Medical School
Wayne State University School of Medicine
1995
Residency
Primary Care Internal Medicine Residency Program, Strong Memorial Hospital, Rochester, NY
1998

· Professional Memberships/Associations

· American Society of Hematology
American Society of Clinical Oncology
Southwest oncology Group, Multiple Myeloma and Special Populations Committees

· Board Certifications

· Michigan State and New York State License
American Board of Internal Medicine
American Board of Internal Medicine - Oncology

· Clinical Interests

· Hematology Oncology

· Research Interests

· Investigation of new drug application for white cell disorders

· Profile

· Dr. Zonder has special interest in multidisciplinary care of patients with Multiple Myeloma, as well as other hematologic cancers.In addition, he is focused on the investigation of therapies for Multiple Myeloma.

· Awards

· 2007 Wayne State University Division of Hematology-Oncology, Hematology Teaching Attending of the Year
2005 Teaching Award, Wayne State University School of Medicine

· Publications

· A phase 1, multicenter, open-label, dose escalation study of elotuzumab in patients with advanced multiple myeloma.Blood. 2011 Dec 19. [Epub ahead of print] Authors: Zonder JA, Mohrbacher AF, Singhal S, van Rhee F, Bensinger WI, Ding H, Fry J, Afar DE, Singhal AK
Perifosine plus bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma previously treated with bortezomib: results of a multicenter phase I/II trial.J Clin Oncol. 2011 Nov 10;29(32):4243-9. Epub 2011 Oct 11. Authors: Richardson PG, Wolf J, Jakubowiak A, Zonder J, Lonial S, Irwin D, Densmore J, Krishnan A, Raje N, Bar M, Martin T, Schlossman R, Ghobrial IM, Munshi N, Laubach J, Allerton J, Hideshima T, Colson K, Poradosu E, Gardner L, Sportelli P, Anderson KC.
Dermatological complications following initiation of lenalidomide in a patient with chronic lymphocytic leukaemia. Intern Med J. 2011 Mar;41(3):286-8. doi: 10.1111/j.1445-5994.2011.02426.x. Authors: Tageja N, Giorgadze T, Zonder J.
Cancer Patient Fracture evaluation (CAFE) Investigators.Balloon kyphoplasty versus non-surgical fracture management for treatment of painful vertebral body compression fractures in patients with cancer: a multicentre, randomised controlled trial. Lancet Oncol. 2011 Mar;12(3):225-35. Epub 2011 Feb 16. Authors: Berenson J, Pflugmacher R, Jarzem P, Zonder J, Schechtman K, Tillman JB, Bastian L, Ashraf T, Vrionis F;
Lenalidomide and high-dose dexamethasone compared with dexamethasone as initial therapy for multiple myeloma: a reandomized Southwest oncology Group trial (S0232). Blood. 2010 Dec 23;116(26):5838-41. Epub 2010 Sep 27. Authors: Zonder JA, Crowlet J, Hussein MA, Bolejack V, Moore DF Sr, Whittenberger BF, Abidi MH, Durie BG, Barlogie B.

1. 添加医学顾问微信，扫描☟二维码

2. 备注【癌种】进病友群

扫描预约专家问诊

专家科普

【3月12日】肿瘤患者怎样避免人财两空？

483全球肿瘤医生网医学部
肿瘤临床试验患者真实采访（下）患者谈：临床试验是小白鼠吗？

591全球肿瘤医生网医学部
肿瘤临床试验患者真实采访（上）临床试验带来的希望

598全球肿瘤医生网医学部
胃癌IV期伴有肝脏及肝胃间隙淋巴结转移患者赴日就医

1333全球肿瘤医生网医学部
大肠癌伴肝转移患者赴日就医

986全球肿瘤医生网医学部
胶质母细胞瘤和髓母细胞瘤患者赴日就医

959全球肿瘤医生网医学部
肝癌患者日本国际就医案例

895全球肿瘤医生网医学部
癌症患者的新方案来了！数十位国际专家带先进技术助力国内癌症患者

1171全球肿瘤医生网医学部